Related Experiment Videos
[Validation of sentinel node in breast cancer]
Omar Vergara-Fernández1, Rubén Cortés-González, Heriberto Medina-Franco
1Dirección de Cirugía, Servicio de Cirugía Oncológica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, DF.
Summary
Sentinel lymph node biopsy accurately predicts breast cancer metastasis, potentially avoiding axillary dissection. Both blue dye and radiocolloid techniques are effective for sentinel lymph node identification.
Area of Science:
- Oncology
- Surgical Pathology
- Diagnostic Imaging
Context:
- Sentinel lymph node biopsy (SLNB) is a crucial staging procedure in breast cancer management.
- Accurate SLNB can obviate the need for more extensive axillary lymph node dissection (ALND).
- Evaluating different SLNB techniques is essential for optimizing patient outcomes.
Purpose:
- To determine the accuracy of sentinel lymph node biopsy (SLNB) in breast cancer staging.
- To compare the efficacy of isosulfan blue dye, technetium-99m-labeled sulfur colloid, and a combination of both for SLNB.
- To assess the predictive value of SLNB for axillary lymph node metastasis.
Summary:
- This study evaluated 61 women undergoing SLNB followed by ALND for breast cancer.
- Three groups received isosulfan blue dye, radiocolloid, or both. SLN identification was 100% successful.
- The SLNB accurately predicted nodal status in 96.77% of cases, with a sensitivity of 91% and negative predictive value of 95%.
Impact:
- SLNB demonstrates high accuracy, supporting its use to avoid standard axillary dissection in node-negative breast cancer patients.
- Both blue dye and radiocolloid techniques are viable for SLNB, though radiocolloid use correlates with a higher number of SLNs removed.
- Accurate SLNB reduces surgical morbidity and improves patient management strategies.